GLP-1's Expanding Horizons: Beyond Weight Loss

GLP-1 receptor agonists offer significant benefits beyond weight loss, including reducing major cardiovascular events, slowing chronic kidney disease progression, and improving fatty liver disease markers.

The top 3

  1. Top 3 Cardiovascular Benefits Identified: GLP-1 RAs consistently reduce major adverse cardiovascular events (MACE) such as myocardial infarction, stroke, and cardiovascular death, even in individuals without diabetes but with obesity and established cardiovascular disease.
  2. Emerging Applications: Kidney & Liver: GLP-1 RAs have demonstrated renoprotective actions, slowing chronic kidney disease progression, and positively impact liver health by improving steatosis and liver inflammation in non-alcoholic fatty liver disease (NAFLD).
  3. Potential in Neurological Disorders Research: Preclinical and some clinical studies suggest GLP-1 RAs have neuroprotective effects, showing potential in treating neurodegenerative diseases like Parkinson's and Alzheimer's, and conditions like idiopathic intracranial hypertension.

Sources

Open the full topic